| 臺北醫學大學 |
2013 |
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism-related enzymes gene polymorphisms, NNK metabolites levels and urothelial carcinoma
|
Chung, CJ;Pu, YS;Shiue, HS;Lee, HL;Lin, P;Yang, YH;Su, CT;Hsueh, YM |
| 臺北醫學大學 |
2013 |
The effect of cigarette smoke and arsenic exposure on urothelial carcinoma risk is modified by glutathione S-transferase M1 gene null genotype
|
Chung, CJ;Huang, CY;Pu, YS;Shiue, HS;Su, CT;Hsueh, YM |
| 國家衛生研究院 |
2012-12 |
A Cullin3-KLHL20 ubiquitin ligase-dependent pathway targets PML to potentiate HIF-1 signaling and prostate cancer progression
|
Lee, YR;Yuan, WC;Huang, SF;Lin, YM;Chen, TY;Chung, HC;Tsai, CH;Chen, HY;Chiang, CT;Lai, CK;Lu, LT;Chen, CH;Gu, DL;Pu, YS;Jou, YS;Lu, K;Hsiao, PW;Shih, HM;Chen, RH |
| 國家衛生研究院 |
2012-11 |
Joint effect of arsenic methylation profile and NNK metabolites on urothelial carcinoma
|
Wu, CC;Su, CT;Lee, HL;Chung, CJ;Huang, CY;Pu, YS;Lin, P;Hsueh, YM |
| 國家衛生研究院 |
2011-08 |
A Cullin3-KLHL20 ubiquitin ligase-dependent pathway targets PML to potentiate HIF-1 signaling and prostate cancer progression
|
Yuan, WC;Lee, YR;Huang, SF;Lin, YM;Chen, TY;Chung, HC;Tsai, CH;Chen, HY;Chiang, CT;Lai, CK;Lu, LT;Chen, CH;Gu, DL;Pu, YS;Jou, YS;Lu, KP;Hsiao, PW;Shih, HM;Chen, RH |
| 中國醫藥大學 |
2011-08 |
Impact of prostate-specific antigen (PSA) nadir and time to PSA nadir on disease progression in prostate cancer treated with androgen-deprivation therapy
|
(Huang SP)*; 鮑柏穎(Bo-Ying Bao); (Wu MT); (Choueiri TK); (Goggins WB); (Huang CY); (Pu YS); (Yu CC); (Huang CH) |
| 國家衛生研究院 |
2011-04 |
Low ratio of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol-glucuronides (NNAL-Gluc)/free NNAL increases urothelial carcinoma risk
|
Chung, CJ;Lee, HL;Yang, HY;Lin, P;Pu, YS;Shiue, HS;Su, CT;Hsueh, YM |
| 中國醫藥大學 |
2011-02 |
Polymorphisms inside MicroRNAs and MicroRNA Target Sites Predict Clinical Outcomes in Prostate Cancer Patients Receiving Androgen-Deprivation Therapy.
|
鮑柏穎(Bo-Ying Bao); (Pao JB); (Huang CN); (Pu YS); 張大元(Ta-Yuan Chang); 藍于琁(Lan Yu Hsuan); 陸德齡(Lu Te-Ling); 李鳳琴(Hong-Zin Lee); 莊聲宏(Shin-Hun Juang); 陳璐敏(Lu-Min Chen); (Hsieh CJ); (Huang SP)* |
| 高雄醫學大學 |
2011 |
Reversed association between levels of prostate specific antigen and levels of blood cadmium and urinary cadmium.
|
楊俊毓; Wu, CC;Pu, YS;Wu, HC;Yang, CY;Chen, YC |
| 中國醫藥大學 |
2011 |
Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen-deprivation therapy
|
鮑柏穎(Bo-Ying Bao); (Pao JB); (Huang CN); (Pu YS); 張大元(Ta-Yuan Chang); 藍于琁(Lan Yu Hsuan); 陸德齡(Lu Te-Ling); 李鳳琴(Hong-Zin Lee); 陳璐敏(Lu-Min Chen); (Ting WC); (Hsieh CJ); (Huang SP)* |
| 中國醫藥大學 |
2011 |
Genetic polymorphisms in androgen receptor-binding sites predict survival in prostate cancer patients receiving androgen-deprivation therapy
|
(Huang CN); (Huang SP); (Pao JB); 張大元(Ta-Yuan Chang); 藍于琁(Lan Yu Hsuan); 陸德齡(Lu Te-Ling); 李鳳琴(Hong-Zin Lee); 莊聲宏(Shin-Hun Juang); 吳玢玢(Wu Ping-Ping); (Pu YS); (Hsieh CJ); 鮑柏穎(Bo-Ying Bao)* |
| 中國醫藥大學 |
2011 |
Significant associations of prostate-specific antigen nadir and time to prostate-specific antigen nadir with survival in prostate cancer patients treated with androgen-deprivation therapy
|
(Huang SP)*; 鮑柏穎(Bo-Ying Bao); (Wu MT); (Choueiri TK); (Goggins WB); (Liu CC); (Huang CY); (Pu YS); (Yu CC); (Wu TT); (Huang CN); (Huang CH); (Wu WJ) |
| 中山醫學大學 |
2010 |
Ling-Zhi polysaccharides potentiate cytotoxic effects of anticancer drugs against drug-resistant urothelial carcinoma cells.
|
Huang, CY; Chen, JY; Wu, JE; Pu, YS; Liu, GY; Pan, MH; Huang, YT; Huang, AM; Hwang, CC; Chung, SJ; Hour, TC |
| 高雄醫學大學 |
2010 |
靈芝萃取物協同增強抗癌藥物毒殺具抗藥性之泌尿上皮癌細胞
|
黃昭淵;陳逸夫;吳嘉恩;蒲永孝;劉光耀;潘敏雄;黃胤塘;黃阿梅;黃啟清;侯自銓 ; Huang CY;Chen Jeff YF;Wu JE;Pu YS;Liu GY;Pan MH;Huang YT;Huang AM;Hwang CC;Chung SJ;Hour TC |
| 高雄醫學大學 |
2010 |
Terpenoids透過ROS誘導細胞週期停滯及凋亡
|
黃阿梅;涂皇堯;侯自銓;蒲永孝;林忠男 ; Chen HL;Lin KW;Huang AM;Tu HY;Wei BL;Hour TC;Yen MH;Pu YS;Lin CN |
| 義守大學 |
2009-12 |
Cadmium burden and the risk and phenotype of prostate cancer
|
Chen YC; Pu YS; Wu HC;Tony T Wu;Lai MK;Yang CY;Sung FC |
| 中國醫藥大學 |
2009-12 |
Cadmium burden and the risk and phenotype of prostate cancer
|
(Chen YC); (Pu YS); (Wu HC); (Wu TT); (Lai MK); (Yang CY); 宋鴻樟(Fung-Chang Sung)* |
| 國家衛生研究院 |
2009-01 |
Correlation between the urine profile of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolites and n(7)-methylguanine in urothelial carcinoma patients [Erratum: Cancer Epidemiology Biomarkers & Prevention. 2008 Dec;17(12):3390-3395.]
|
Lee, HL;Hsueh, YM;Chung, CJ;Pu, YS;Chang, LW;Hsieh, DPH;Liou, SH;Lin, P |
| 臺北醫學大學 |
2009 |
Arsenic Methylation Capability; Myeloperoxidase (MPO) and sulfortransferase (SULT 1A1) Genetic Polymorphisms; and the Stage and Grade of Urothelial Carcinoma
|
薛玉梅; Huang Steven K; Chiu Allen WH; Pu YS; Huang YK; Chung CJ; Tsai HJ; Yang MH; Chen CJ; Hsueh YM |
| 臺北醫學大學 |
2009 |
Clinicopathological characteristics and survival outcome of arsenic related bladder cancer in Taiwan
|
薛玉梅; Chen CH; Chiou HY; Hsueh YM; Chen CJ; Yu HJ; Pu YS |
| 臺北醫學大學 |
2009 |
Clinical Pathological characteristics and survival outcome of arsenic-related bladder cancer in Taiwan.
|
邱弘毅; Chen CH; Chiou HY; Hsieh YM; Chen CJ; Yu HJ; Pu YS |
| 中山醫學大學 |
2009 |
Downregulation of ABCD1 in human renal cell carcinoma.
|
Hour, TC; Kuo, YZ; Liu, GY; Kang, WY; Huang, CY; Tsai, YC; Wu, WJ; Huang, SP; Pu, YS |
| 高雄醫學大學 |
2009 |
Cadmium burden and the risk and phenotype of prostate cancer.
|
楊俊毓; Chen, YC;Pu, YS;Wu, HC;Wu, TT;Lai, MK;Yang, CY; , Sung FC |
| 國家衛生研究院 |
2008-12-01 |
Correlation between the urine profile of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolites and N7-methylguanine in urothelial carcinoma patients
|
Lee, HL;Hsueh, YM;Chung, CJ;Pu, YS;Chang, LW;Hsieh, DPH;Liou, SH;Lin, P |
| 國立臺灣大學 |
2008-11 |
Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinoma
|
Lin, CC; Pu, YS; Hsu, CH; Keng, HY; Cheng, AL; Yang, CH |
| 國立臺灣大學 |
2008-01 |
Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area
|
Chung, CJ; Huang, CJ; Pu, YS; Su, CT; Huang, YK; Chen, YT; Hsueh, YM |
| 臺北醫學大學 |
2008 |
Androgen receptor gene polymorphism may affect the risk of urothelial carcinoma.
|
薛玉梅; Liu CH; Huang JD; Huang SW; Hour TC; Huang YK; Hsueh YM; Chiou HY; Lee TC; Jan KY; Chen CJ; Pu YS |
| 臺北醫學大學 |
2008 |
Arsenic Methylation Capability; Heme Oxygenase-1 and NADPH Quinone Oxidoreductase-1 Genetic Polymorphisms; and the Stage and Grade of Urothelial Carcinomas
|
薛玉梅; Huang Steven K; Chi Allen WH; Pu YS; Huang YK; Chung CJ; Tsai HJ; Yang MH; Chen CJ; Hsueh YM |
| 臺北醫學大學 |
2008 |
Correlation Between the Urine Profile of 4-(Methylnitrosamino)- 1-(3-Pyridyl)-1-Butanone Metabolites and 7-Methylguanine in Urothelial Carcinoma Patients.
|
薛玉梅; Lee HL; Hsueh YM; Chung CJ; Pu YS; Chang LW; Hsieh DPH; Liou SH; Lin P. |
| 臺北醫學大學 |
2008 |
Plasma Folate Level; Urinary Arsenic Methylation Profiles; and Urothelial Carcinoma Susceptibility.
|
薛玉梅; Huang YK; Pu YS; Chung CJ; Shiue HS; Yang MH; Chen CJ; Hsueh YM |
| 臺北醫學大學 |
2008 |
Polymorphisms in cell cycle regulatory genes; urinary arsenic profile and urothelial carcinoma.
|
薛玉梅; Chung CJ; Huang CJ; Pu YS; Su CT; ; Huang YK; Chen YT; Hsueh YM |
| 臺北醫學大學 |
2008 |
Urinary 8-Hydroxydeoxyguanine Levels in Urothelial Carcinoma Patients with Low Urinary Arsenic Concentrations.
|
薛玉梅; Chung CJ; Huang CJ; Pu YS; Su CT; Huang YK; Chen YT; Hsueh YM |
| 臺北醫學大學 |
2008 |
Androgen receptor gene polymorphism may affect the risk of urothelial carcinoma
|
邱弘毅; Liu CH; Huang JD; Huang SW; Hour TC; Huang YK; Hsueh YM; Chiou HY; Lee TC; Jan KY; Chen CJ; Pu YS |
| 中山醫學大學 |
2008 |
Down-regulated expression of RhoA in human conventional renal cell carcinoma.
|
Pu, YS; Wang, CW; Liu, GY; Kuo, YZ; Huang, CY; Kang, WY; Shun, CT; Lin, CC; Wu, WJ; Hour, TC |
| 國立臺灣大學 |
2007-08 |
Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer
|
Chen, CH; Shun, CT; Huang, KH; Huang, CY; Tsai, YC; Yu, HJ; Pu, YS. |
| 國立臺灣大學 |
2007-06 |
Long-term follow-up of hand-assisted laparoscopic radical nephrectomy for organ-confined renal cell carcinoma.
|
Chung, SD; Huang, KH; Lai, MK; Huang, CY; Pu, YS; Yu, HJ; Chueh, SC |
| 國立臺灣大學 |
2007-04 |
Long-term follow-up of hand-assisted laparoscopic radical nephrectomy for organ-confined renal cell carcinoma.
|
Chung, SD; Huang, KH; Lai, MK; Huang, CY; Pu, YS; Yu, HJ; Chueh, SC. |
| 臺北醫學大學 |
2007 |
Urinary Arsenic Profile Affects the Risk of Urothelial Carcinoma even at Low Arsenic Exposure
|
薛玉梅; Pu YS; Yang SM; Huang YK; Chung CJ.; Huang Steven K; Chiu Allen WH; Yang MH; Chen CJ; Hsueh YM |
| 高雄醫學大學 |
2007 |
以低量paclitaxel與高劑量5-fluorouracil 同時結合leucovorin治療賀爾蒙反拗之前列腺癌：In Vitro藥物結合 與臨床phase II 實驗結果
|
林家齊;徐志宏;侯自銓;鄭安理;黃昭淵;黃國皓;陳淳;蒲永孝 ; Lin CC;Hsu CH;Hour TC;Cheng AL;Huang CY;Huang KH;Chen J;Pu YS |
| 高雄醫學大學 |
2007 |
p53與XRCC1基因多型性在攝護腺癌術後攝護腺特異抗原復發的預後角色
|
黃書彬;昭淵, 黃;王志生;劉家駒;蒲永孝;余宏政;余家政;吳東霖;黃俊雄;吳文正;周以和;吳明蒼; Huang, SP;Huang, CY;Wang, JS;Liu, CC;Pu, YS;Yu, HJ;Yu, CC;Wu, TT;Huang, CH;Wu, WJ;Chou, YH;Wu, MT |
| 國立臺灣大學 |
2006-06 |
Transurethral resection of bladder tumors followed by radiotherapy with or without chemotherapy for bladder preservation in patients with invasive bladder transitional cell carcinoma: Preliminary NTUH experience
|
Hsu, FM; Cheng, JC; Pu, YS; Lin, CC; Lai, MK |
| 高雄醫學大學 |
2006 |
上皮生長因子受體抑制劑PD168393加強雄性激素不依賴前列腺癌細胞毒性作用
|
蒲永孝;謝旻娓;王壯維;劉光耀;黃昭淵;林家齊;林信仁;侯自銓; Pu YS;Hsieh MW;Wang CW;Liu GY;Huang CY;Lin CC;Guan JY;Lin SR;Hour TC |
| 臺北醫學大學 |
2005 |
Comparison with Urinary Cotinine Levels and Respiratory Health Effects between Light and Heavy Smokers.
|
葉錦瑩; Hsueh YM; Chung CJ; Huang YK; Pu YS; Huang SK; Chen CJ |
| 臺北醫學大學 |
2005 |
Database Analysis and Risk Factors Investigation for Occupational Noise-induced Hearing Loss.
|
葉錦瑩; Hsueh YM; Chen YT; Tsai HJ; Chung CJ; Huang YK; Pu YS; Chen CJ |
| 高雄醫學大學 |
2005 |
細胞對太平洋紫衫醇抗性與其抗氧化能力呈正相關係
|
陳建宏;詹崑源;侯自銓;余宏政;蒲永孝 ; Ramanathan B;Jan KY;Chen CH;Hour TC;Yu HJ;Pu YS |
| 中國醫藥大學 |
2005 |
Diet, vegetarian food and prostate carcinoma among men in Taiwan
|
Chen, YC; Chiang, CI; Lin, RS; Pu, YS; Lai, MK; Sung, FC |
| 國家衛生研究院 |
2004-12 |
Negative modulation of androgen receptor transcriptional activity by Daxx
|
Lin, DY; Fang, HI; Ma, AH; Huang, YS; Pu, YS; Jenster, G; Kung, HJ; Shih, HM |
| 國立臺灣大學 |
2004-12 |
Intleukin-6 is responsible for drug resistance and anti-apoptotic effects in prostatic cancer cells.
|
Pu, YS; Hour, TC; Chuang, SE; Cheng, AL; Lai, MK; Kuo, ML |
| 國家衛生研究院 |
2004-07-01 |
Interleukin-6 is responsible for drug resistance and anti-apoptotic effects in prostatic cancer cells
|
Pu, YS; Hour, TC; Chuang, SE; Cheng, AL; Lai, MK; Kuo, ML |
| 國立臺灣大學 |
2004-07 |
RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts.
|
Tsuei, DJ; Hsu, HC; Lee, PH; Jeng, YM; Pu, YS; Chen, CN; Lee, YC; Chou, WC; Chang, CJ; Ni, YH; Chang, MH. |
